Clazakizumab
id:
clazakizumab-310-13327737
title:
Clazakizumab
text:
Clazakizumab, an investigational drug, is an aglycosylated, humanized rabbit monoclonal antibody against interleukin-6. Clazakizumab was developed by Bristol Myers Squib and Alder Biopharmaceuticals. A preliminary randomized, double-blind, placebo-controlled, phase 2 dose-ranging study of clazakizumab in psoriatic arthritis patients, funded by the manufacturer, suggested that clazakizumab may be an effective treatment option for musculoskeletal aspects of psoriatic arthritis; however, the antibo
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Clazakizumab
date created:
date modified:
2023-12-02T07:01:06Z
main entity:
{"identifier":"Q3601001","url":"https://www.wikidata.org/entity/Q3601001"}
image:
fields total:
13
integrity:
14